Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience

World J Urol. 2021 Dec;39(12):4305-4310. doi: 10.1007/s00345-021-03792-5. Epub 2021 Jul 27.


Objective: To describe our institution's initial experience with robot-assisted radical prostatectomy (RARP) using the Senhance® robotic system.

Patients and methods: A prospective analysis of 127 robot-assisted radical prostatectomies was performed. Patient demographics, preoperative and intraoperative parameters, histopathological examination results, intraoperative and early postoperative complications were obtained and analyzed.

Results: The median patient age was 61.0 ± 6.36 (from 37 to 73) years, with a mean body mass index of 26.2 ± 3.79 kg/m2. Of 127 patients, 16.5% (n = 21) underwent a pelvic lymph node dissection, 29.1% (n = 37) underwent one sided or bilateral nerve sparing. Post-operative extracapsular invasion (≥ pT3) was found in 15% (n = 19) of the cases and a Gleason score ≥ 7 in 74.8% of all patients. Our median operative time was 180 ± 41.98 min [interquartile range (IQR) 150-215], and median blood loss was 250 ± 236 (IQR 175-430) ml. Of 127 patients, 33.9% (n = 43) had positive margins, of them 28.7% in pT2 and 57.9% in pT3. Fifteen patients (11.8%) experienced complications, of them only three had Clavien-Dindo ≥ 3. Operation time decreased by about 60 min and estimated blood loss decreased by about 200 ml from the initial experience of each surgeon.

Conclusions: Robotic prostatectomy using a Senhance® robotic system is feasible, and warrants further study to determine whether it can improve patient outcomes.

Keywords: Minimally invasive surgery; Prostate cancer; Prostatectomy; Robotic surgery; Senhance® robotic system.

MeSH terms

  • Adult
  • Aged
  • Equipment Design
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prostatectomy / methods*
  • Prostatic Neoplasms / surgery*
  • Robotic Surgical Procedures / instrumentation*